Join to View Full Profile
4101 N Roxboro StDurham, NC 27704
Phone+1 919-684-8111
Dr. Schmader is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Geriatric Medicine (Internal Medicine), 1986 - 1988
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1980
Certifications & Licensure
NC State Medical License 1983 - 2025
American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Top MD Consumers Checkbook
Clinical Trials
- Silk-Like Fabric for the Prevention of Pressure Sores in a Long Term Care Setting Start of enrollment: 2010 Sep 01
- Evaluate the Efficacy of a Silk-Like Fabric for the Prevention of Pressure Sores in a Long Term Care Setting Start of enrollment: 2010 Sep 01
- Discharge Information and Support for Patients Receiving Outpatient Care in the Emergency Department Start of enrollment: 2013 Dec 01
Publications & Presentations
PubMed
- Can Pharmacogenetics Be Used to Predict the Response to Fesoterodine Fumarate?Jennifer M Wu, Nazema Y Siddiqui, Tim Wiltshire, Deepak Voora, Kenneth Schmader
Urogynecology. 2025-02-14 - Population Pharmacokinetics of Meropenem Across the Adult Lifespan.Angelique E Boutzoukas, Stephen J Balevic, Marion Hemmersbach-Miller, Patricia L Winokur, Kenan Gu
Clinical Pharmacokinetics. 2025-02-01 - Medication Use Quality and Safety in Older Adults: 2023 Update.Laura A Hart, Su Vo, Joseph T Hanlon, Kenneth E Schmader, Shelly L Gray
Journal of the American Geriatrics Society. 2025-01-27
Journal Articles
- Safety, Reactogenicity, and Health-Related Quality of Life After Trivalent Adjuvanted vs Trivalent High-Dose Inactivated Influenza Vaccines in Older AdultsKenneth E Schmader, Christine K Liu, Heidi Auerbach, Elizabeth D Barnett, Elizabeth P Schlaudecker, Mary A Staat, JAMA Network Open
- Update on Medication Use Quality and Safety in Older Adults, 2017Shelly L Gray, Joseph T Hanlon, Kenneth E Schmader, Journal of the American Geriatrics Society
- The Impact of Reactogenicity After the First Dose of Recombinant Zoster Vaccine Upon the Physical Functioning and Quality of Life of Older Adults: An Open Phase III TrialMyron J Levin, David Butuk, Kenneth E Schmader, Charles Fogarty, Paul Hartley, Max Nevarez, Nicola P Klein, Kari Uusinarkaus, The Journals of Gerontology
Press Mentions
Simultaneous Adjuvant Flu, RZV Vaccines a Safe, ‘Acceptable Option’ for Older AdultsOctober 24th, 2024- The Physical and Personal Cost of COVID-19 and SeniorsMay 25th, 2021
New Shingles Vaccine: What You Need to KnowFebruary 12th, 2018- Join now to see all
Grant Support
- Duke Claude D. Pepper Older Americans Independence CenterDUKE UNIVERSITY2006–2026
- Herpes Zoster And Medications In The ElderlyNational Institute Of Allergy And Infectious Diseases2001–2005
- Impact Of Geriatric Care On Drug Related ProblemsNational Institute On Aging1996–2000
- Epidemiology Of Herpes Zoster And Postherpetic NeuralgiaNational Institute On Aging1991–1995
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
